Role of statins in cerebral vasospasm
- PMID: 18457003
- PMCID: PMC2743544
- DOI: 10.1007/978-3-211-75718-5_59
Role of statins in cerebral vasospasm
Abstract
3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, commonly known as statins, are widely used clinically for their lipid lowering properties. Recent evidence shows that statins are also effective in ameliorating cerebral vasospasm, which occurs as sequelae of subarachnoid haemorrhage. This review focuses on the pleiotropic effects of statins, and the putative mechanisms involved in statin mediated attenuation of cerebral vasospasm.
Figures

Similar articles
-
Mechanisms of statin treatment in cerebral vasospasm.Acta Neurochir Suppl. 2011;110(Pt 2):9-11. doi: 10.1007/978-3-7091-0356-2_2. Acta Neurochir Suppl. 2011. PMID: 21125437 Review.
-
Statin treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.Ann Pharmacother. 2007 Dec;41(12):2019-23. doi: 10.1345/aph.1K301. Epub 2007 Nov 6. Ann Pharmacother. 2007. PMID: 17986515 Review.
-
Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.J Neurosurg. 2017 Aug;127(2):291-301. doi: 10.3171/2016.5.JNS152900. Epub 2016 Oct 7. J Neurosurg. 2017. PMID: 27715439
-
Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase.J Neurosci Res. 2008 Dec;86(16):3635-43. doi: 10.1002/jnr.21807. J Neurosci Res. 2008. PMID: 18683242 Free PMC article.
-
Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.Stroke. 2002 Dec;33(12):2950-6. doi: 10.1161/01.str.0000038986.68044.39. Stroke. 2002. PMID: 12468796
Cited by
-
High-Dose Simvastatin Is Effective in Preventing Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study in Korean Patients.J Korean Neurosurg Soc. 2015 Oct;58(4):328-33. doi: 10.3340/jkns.2015.58.4.328. Epub 2015 Oct 30. J Korean Neurosurg Soc. 2015. PMID: 26587185 Free PMC article.
-
Pleiotropic effects of the HMG-CoA reductase inhibitors.Int J Gen Med. 2011 Apr 4;4:261-71. doi: 10.2147/IJGM.S16779. Int J Gen Med. 2011. PMID: 21556312 Free PMC article.
-
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.Stroke. 2019 Mar;50(3):738-744. doi: 10.1161/STROKEAHA.118.024058. Stroke. 2019. PMID: 30744543 Free PMC article.
-
Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.Sci Rep. 2014 Apr 25;4:4573. doi: 10.1038/srep04573. Sci Rep. 2014. PMID: 24763190 Free PMC article.
-
Statins in the critically ill.Ann Intensive Care. 2012 Jun 18;2(1):19. doi: 10.1186/2110-5820-2-19. Ann Intensive Care. 2012. PMID: 22709377 Free PMC article.
References
-
- Borel CO, McKee A, Parra A, Haglund MM, Solan A, Prabhakar V, Sheng H, Warner DS, Niklason L. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003;34:427–433. - PubMed
-
- Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med. 2000;6:1362–1367. - PubMed
-
- Budzyn K, Marley PD, Sobey CG. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension. J Pharmacol Exp Ther. 2005;313:1248–1253. - PubMed
-
- Budzyn K, Marley PD, Sobey CG. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease. Trends Pharmacol Sci. 2006;27:97–104. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical